Withholding intravenous drugs did not improve survival to hospital discharge in out-of-hospital cardiac arrest

Stiell, Ian G.
March 2010
ACP Journal Club;3/16/2010, Vol. 152 Issue 3, p7
Academic Journal
The article offers information on a medical research related to intravenous drugs. It explores the effectiveness of withholding intravenous (IV) drugs in improvement of patient's health with out-of-hospital cardiac arrest. It concludes in a clinical trial that withholding intravenous drugs did not improve the rate of survival to hospital discharge.


Related Articles

  • Sulfadoxine-Pyrimethamine-Based Combinations for Malaria: A Randomised Blinded Trial to Compare Efficacy, Safety and Selection of Resistance in Malawi. Bell, David J.; Nyirongo, Suzgo K.; Mukaka, Mavuto; Zijlstra, Ed E.; Plowe, Christopher V.; Molyneux, Malcolm E.; Ward, Steve A.; Winstanley, Peter A. // PLoS Clinical Trials;Feb2008, Vol. 5 Issue 2, Special section p1 

    Background: In Malawi, there has been a return of Plasmodium falciparum sensitivity to chloroquine (CQ) since sulfadoxinepyrimethamine (SP) replaced CQ as first line treatment for uncomplicated malaria. When used for prophylaxis, Amodiaquine (AQ) was associated with agranulocytosis but is...

  • A pharmacovigilance study with dexibuprofen. Ceraso, O. L. // Inflammopharmacology;1999, Vol. 7 Issue 3, p328 

    Presents information on a study which assessed the efficacy and tolerability of dexibuprofen in the treatment of acute painful conditions of patients. Analysis of the clinical trials for the treatment of pain; Use of nominal scale in numeric value assessment; Degree of pain reduction from trials.

  • Vaccine for Chickenpox.  // Saturday Evening Post;Sep/Oct1973, Vol. 245 Issue 5, p139 

    Reports on the success of the clinical trials for chickenpox vaccine in Japan as of September 1973. Subjects used by researcher Doctor Takaki Tadahashi in the study; Schedule of the start of the commercial production of the vaccine.

  • Acorda reports positive data from heart failure study.  // PharmaWatch: Biotechnology;Sep2008, Vol. 7 Issue 9, p10 

    The article reports on the positive results of the preclinical trial for neuregulin molecule GGF2 manufactured by Acorda Therapeutics Inc. The trial reveals that GGF2 provided more benefits than the other neuregulin fragments by strengthening and protecting the heart muscle cells. The data...

  • Gabapentin and nortriptyline combined was better than either drug alone for relief of neuropathic pain. Hughes, James // ACP Journal Club;3/16/2010, Vol. 152 Issue 3, p5 

    The article focuses on a medical research related to effectiveness of combined gabapentin and nortriptyline in comparison to alone drug for neuropathic pain. In a clinical trial around 56 patients with neuropathy is being observed and treated with combined drugs. It concluded that gabapentin and...

  • Zinc Lozenges May Shorten the Duration of Colds: A Systematic Review. Hemilä, Harri // Open Respiratory Medicine Journal;2011, Vol. 5, p51 

    Background: A number of controlled trials have examined the effect of zinc lozenges on the common cold but the findings have diverged. The purpose of this study was to examine whether the total daily dose of zinc might explain part of the variation in the results. Methods: The Medline, Scopus...

  • Comparing Highly Efficacious Antimalarial Drugs. Sutherland, Colin J. // PLoS Clinical Trials;Nov2008, Vol. 5 Issue 11, p1544 

    The article discusses research on highly effective antimalarial drugs. It references the study "Revisiting the Design of Phase III Clinical Trials of Antimalarial Drugs for Uncomplicated Plasmodium Falciparum Malaria," by Steffen Borrmann et al, published in the same issue. A non-inferiority...

  • Safinamide Falls Short In Trial; Long-Term View Good.  // Bioworld Week;8/27/2007, Vol. 15 Issue 35, p4 

    The article reports that Newron Pharmaceuticals' long term efficacy of Phase III trial testing of safinamide in the treatment of Parkinson's disease was not successful in the U.S. The objective of the study is to assess the long-term safety and efficacy of the drug as an add-on treatment to...

  • Comparison of Azithromycin and Doxycycline in the Treatment of Erythema migrans. Barsic, B.; Maretic, T.; Majerus, L.; Strugar, J. // Infection;Jun2000, Vol. 28 Issue 3, p153 

    Background:A randomized, multicenter, open clinical trial was undertaken in order to compare the efficacies of azithromycin and doxycycline in the treatment of patients with Lyme disease associated with erythema migrans. Patients and Methods: A total of 48 patients was treated orally with...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics